Lakeshore Capital Group Inc. Acquires New Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Lakeshore Capital Group Inc. purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 1,265 shares of the healthcare conglomerate's stock, valued at approximately $640,000.

Several other hedge funds have also modified their holdings of the business. Heck Capital Advisors LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at $1,649,000. Armis Advisers LLC purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $282,000. Polar Asset Management Partners Inc. bought a new stake in UnitedHealth Group in the fourth quarter valued at about $1,973,000. Garde Capital Inc. increased its holdings in UnitedHealth Group by 17.1% in the fourth quarter. Garde Capital Inc. now owns 616 shares of the healthcare conglomerate's stock valued at $312,000 after buying an additional 90 shares during the last quarter. Finally, Hall Capital Management Co. Inc. bought a new stake in UnitedHealth Group in the fourth quarter valued at about $2,351,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

UnitedHealth Group stock traded down $0.58 during midday trading on Tuesday, hitting $294.99. The stock had a trading volume of 20,069,744 shares, compared to its average volume of 6,655,522. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73. The firm's fifty day moving average is $448.25 and its two-hundred day moving average is $501.48. The company has a market capitalization of $267.60 billion, a PE ratio of 19.03, a P/E/G ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The business had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter last year, the business posted $6.91 earnings per share. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director John H. Noseworthy purchased 300 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were bought at an average cost of $312.16 per share, for a total transaction of $93,648.00. Following the completion of the purchase, the director now directly owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy Patrick Flynn bought 1,533 shares of the business's stock in a transaction that occurred on Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This trade represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock worth $31,607,768 over the last quarter. Insiders own 0.33% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $525.00 to $355.00 and set an "outperform" rating for the company in a research report on Friday, May 16th. TD Cowen lowered UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a report on Monday, May 19th. Truist Financial reaffirmed a "buy" rating and issued a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $677.00 to $351.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Finally, Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $441.87.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.